Although GAL expression was not associated with conventional clinicopathological risk factors in stage II CRC, such as T4 stage, lymphovascular invasion of tumor cells, and pathologic surgical margin involvement, higher GAL expression was an independent poor prognostic factor for OS and RFS in multivariate analysis. The gene discussed is GAL; the disease is colorectal carcinoma.